Dominick John Gadaleta, MD
Otolaryngology · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Og Medical Inc · 2 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gadaleta’s office at (804) 513-6252 to ask if they take your plan before you enroll.
California Medical Board record
Licence A169091 · Current
Licensed to practise in California · since 2020 · expires 2028-06-30 · Boston University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Drugs they prescribed that Part D paid
$1,323
Pharmacies billed $1,323 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (11 of 97) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
96 generic and fewer than 11 brand-name prescriptions · $1,323 in drug cost · 16 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 14 | $333 | $24 |
| Cephalexin | 12 | $154 | $13 |
Year by year
| 2024 | 97 | 19 | 11% (11) | None | $1,323 |
| 2023 | 46 | None | None | None | $774 |
| 2022 | 33 | None | None | None | $847 |
| 2019 | 31 | 15 | None | None | $250 |
| 2018 | 53 | 26 | 34% (18) | None | $616 |
| 2017 | 80 | 41 | 40% (32) | 0% | $949 |
| 2016 | 74 | 35 | 42% (31) | None | $1,047 |
| 2015 | 62 | 34 | 27% (17) | None | $4,521 |
| 2014 | 21 | 11 | None | None | $2,727 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 2 drugs
| Methylprednisolone | 13 | $144 | $11 |
| Hydrocodone-Acetaminophen | 16 | $66 | $4 |
2017: 3 drugs
| Cefdinir | 16 | $257 | $16 |
| Methylprednisolone | 14 | $218 | $16 |
| Hydrocodone-Acetaminophen | 26 | $104 | $4 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 23 | $162 | $7 |
2015: 2 drugs
| Cefdinir | 12 | $251 | $21 |
| Hydrocodone-Acetaminophen | 16 | $129 | $8 |
Money from drug and device companies
$362 in 2025
| 2025 | 3 | 7 | None | $362 |
| 2024 | 2 | 8 | None | $177 |
| 2023 | 3 | 3 | None | $147 |
| 2022 | 2 | 5 | None | $317 |
| 2021 | 3 | 10 | None | $601 |
| 2020 | 1 | 1 | None | $37 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | None | $193 | 5 payments
|
| Abbvie | Botox | $128 | 1 payment
|
| Hologic Sales and Service | Coolseal Generator | $41 | 1 payment
|
See all 7 published payments
| Hologic Sales and Service | Meals · 2025-12-16 | Coolseal Generator | $41 |
| Galderma Laboratories L.P. | Meals · 2025-12-04 | None | $13 |
| Galderma Laboratories L.P. | Meals · 2025-09-20 | None | $130 |
| Galderma Laboratories L.P. | Meals · 2025-08-27 | None | $10 |
| Abbvie | Meals · 2025-04-25 | Botox | $128 |
| Galderma Laboratories L.P. | Meals · 2025-03-18 | None | $10 |
| Galderma Laboratories L.P. | Meals · 2025-03-07 | None | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $177
| Abbvie | Botox | $131 | 6 payments
|
| Galderma Laboratories L.P. | Dysport | $45 | 2 payments
|
2023: $147
| Galderma Laboratories L.P. | None | $105 | 1 payment
|
| Abbvie | Botox | $23 | 1 payment
|
| Merz North America | Xeomin | $18 | 1 payment
|
2022: $317
| Abbvie | None | $202 | 1 payment
|
| Allergan | Botox | $114 | 4 payments
|
2021: $601
| Merz North America | Xeomin | $452 | 3 payments
|
| Allergan | None | $89 | 4 payments
|
| Galderma Laboratories L.P. | None | $59 | 3 payments
|
2020: $37
| Merz North America | Xeomin | $37 | 1 payment
|
Professional record
- NPI
- 1114339942
- Licence
- CA 169091California A169091: Current · expires 2028-06-30
- Trained
- Boston University School of Medicine, 2014
- Group
- Og Medical Inc
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207YS0123X (207YS0123X); Student in a training program (390200000X)
- Mailing address
- 1795 El Camino Real Ste 200, Palo Alto, CA, 94306
- NPI first listed
- 2014-05-28
- NPI last updated
- 2020-11-20
- NPI record certified
- 2020-11-20
This is when the NPI record was last certified, not a medical board exam.